CRO and sponsor site selection decisions are frequently described as relationship-based or PI-dependent. The reality, based on published research, is that site selection is primarily data-driven, and the data that matters most is enrollment history. Sites that understand what that data consists of — and how to improve it — have a measurable advantage in study acquisition over sites that compete on relationships and hope.
Speed Is the Primary Variable
A 2019 study published in PMC surveying 83 biopharmaceutical and CRO decision-makers found that 88 percent would prefer to see enrollment goals reached 10 percent faster rather than cut costs by 20 percent. The implication is straightforward: sites that compete primarily on budget — accepting lower per-patient fees to win studies — are optimizing for the metric that matters least to the people making selection decisions.
First-patient-in speed — the number of days from site activation to the first enrolled patient — was rated the most important site quality factor by 42 percent of respondents. Sites that have enrollment infrastructure in place before activation, and that activate existing physician referral relationships as soon as the study opens, consistently achieve faster FPI than sites building their recruitment approach from scratch after activation.
Historical Enrollment Rate as the Dominant Predictor
CROs maintain internal performance records for sites they have worked with previously. When a new study goes to site selection, those historical records are the first filter. Sites with consistent enrollment track records — achieving 80 percent or more of their enrollment target within the projected timeline — are offered more studies, offered more complex studies, and are offered studies with earlier in the selection process.
Sites with no track record (new sites) or inconsistent track records are offered fewer opportunities and are subject to more stringent feasibility review. This creates a compounding dynamic: sites that enroll well attract more studies, which gives them more opportunities to enroll well, which reinforces their performance record.
Data Quality Metrics as Secondary Filters
After enrollment speed and historical rate, CROs evaluate two data quality metrics: database query rate and protocol deviation rate. Database queries are corrections requested by the sponsor's data management team when submitted data is incomplete, inconsistent, or violates protocol rules. A high query rate signals that the site is generating data with systematic errors — a serious concern for sponsors managing regulatory submissions.
Protocol deviation rate measures how often the site departs from study protocol. High deviation rates suggest inadequate training, understaffed coordination teams, or poor protocol compliance infrastructure. Both metrics are tracked per site and per study, and both are weighted in future selection decisions.
What Sites Get Wrong About Competing for Studies
The most common mistake sites make in competing for study grants is treating the feasibility questionnaire as a form-filling exercise rather than a competitive document. Feasibility responses that contain enrollment projections based on PI estimates rather than data, that do not describe the site's physician outreach infrastructure, and that take more than a week to return, perform worse in selection outcomes than responses built on real data, submitted quickly, and structured to answer the CRO's actual question: can this site enroll patients as fast as it says it can?
Sites that can answer that question with documentation — a physician contact count, an active outreach status, and a historical enrollment conversion rate — answer it better than sites that cannot. That difference is visible in the selection outcome.